Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [1] Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease
    Cho, Do-Yeon
    Zhang, Shaoyan
    Lazrak, Ahmed
    Grayson, Jessica W.
    Garcia, Jaime A. Pena
    Skinner, Daniel F.
    Lim, Dong Jin
    Mackey, Calvin
    Banks, Catherine
    Matalon, Sadis
    Woodworth, Bradford A.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2019, 9 (01) : 100 - 105
  • [2] Novel S-Nitrosothiols Have Potential Therapeutic Uses for Cystic Fibrosis
    Zaman, Khalequz
    Fraser-Butler, Maya
    Bennett, Deric
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (19) : 3509 - 3520
  • [3] New Therapeutic Approaches in Cystic Fibrosis
    Fakioglu, Dolunay Merve
    Altun, Beril
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 17 (06) : 686 - 697
  • [4] Harnessing the therapeutic potential of phytochemicals in neuroblastoma
    Ahmadi, Seyed Sajad
    Bagherzadeh, Omid
    Sargazi, Meysam
    Kalantar, Farnaz
    Najafi, Mohammad Amin Elahi
    Vahedi, Mohammad Mahdi
    Afshari, Amir R.
    Sahebkar, Amirhossein
    BIOFACTORS, 2025, 51 (01)
  • [5] Novel Approaches for Potential Therapy of Cystic Fibrosis
    Sawczak, Victoria
    Getsy, Paulina
    Zaidi, Aliya
    Sun, Fei
    Zaman, Khalequz
    Gaston, Benjamin
    CURRENT DRUG TARGETS, 2015, 16 (09) : 923 - 936
  • [6] Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
    Guan, Xiaoqing
    Hou, Yuning
    Sun, Fei
    Yang, Zhe
    Li, Chunying
    CURRENT DRUG TARGETS, 2016, 17 (13) : 1535 - 1544
  • [7] Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
    Consalvi, Sara
    Poce, Giovanna
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    Patrignani, Paola
    Bruno, Annalisa
    Anzini, Maurizio
    Calderone, Vincenzo
    Martelli, Alma
    Testai, Lara
    Giordani, Antonio
    Biava, Mariangela
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 210
  • [8] PPARγ as a therapeutic target in cystic fibrosis
    Dekkers, Johanna F.
    van der Ent, Cornelis K.
    Kalkhoven, Eric
    Beekman, Jeffrey M.
    TRENDS IN MOLECULAR MEDICINE, 2012, 18 (05) : 283 - 291
  • [9] Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies
    Moni, Sivakumar S.
    Al Basheer, Asmaa
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (12) : 1736 - 1747
  • [10] Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
    Meijer, Laurent
    Nelson, Deborah J.
    Riazanski, Vladimir
    Gabdoulkhakova, Aida G.
    Hery-Arnaud, Genevieve
    Le Berre, Rozenn
    Loaec, Nadege
    Oumata, Nassima
    Galons, Herve
    Nowak, Emmanuel
    Gueganton, Laetitia
    Dorothee, Guillaume
    Prochazkova, Michaela
    Hall, Bradford
    Kulkarni, Ashok B.
    Gray, Robert D.
    Rossi, Adriano G.
    Witko-Sarsat, Veronique
    Norez, Caroline
    Becq, Frederic
    Ravel, Denis
    Mottier, Dominique
    Rault, Gilles
    JOURNAL OF INNATE IMMUNITY, 2016, 8 (04) : 330 - 349